Phibro Animal Health Corp. (NASDAQ:PAHC) was downgraded by equities researchers at Gabelli from a “buy” rating to a “hold” rating in a research note issued to investors on Thursday.

A number of other equities research analysts have also recently commented on the stock. TheStreet raised shares of Phibro Animal Health Corp. from a “sell” rating to a “hold” rating in a research note on Wednesday, September 14th. Zacks Investment Research raised shares of Phibro Animal Health Corp. from a “strong sell” rating to a “hold” rating in a research note on Wednesday, November 2nd. Credit Suisse Group AG reaffirmed a “buy” rating and set a $29.00 price target on shares of Phibro Animal Health Corp. in a research note on Tuesday, August 30th. Guggenheim set a $30.00 price target on shares of Phibro Animal Health Corp. and gave the stock a “buy” rating in a research note on Monday, September 12th. Finally, Morgan Stanley set a $23.00 price target on shares of Phibro Animal Health Corp. and gave the stock a “sell” rating in a research note on Sunday, September 4th. Three equities research analysts have rated the stock with a sell rating, two have issued a hold rating and three have given a buy rating to the stock. Phibro Animal Health Corp. has an average rating of “Hold” and an average target price of $26.80.

Analyst Recommendations for Phibro Animal Health Corp. (NASDAQ:PAHC)

Phibro Animal Health Corp. (NASDAQ:PAHC) opened at 28.70 on Thursday. Phibro Animal Health Corp. has a one year low of $16.80 and a one year high of $35.69. The company has a 50 day moving average of $26.41 and a 200-day moving average of $22.34. The firm has a market cap of $1.13 billion, a PE ratio of 15.03 and a beta of 1.38.

Phibro Animal Health Corp. (NASDAQ:PAHC) last issued its quarterly earnings data on Wednesday, November 9th. The company reported $0.36 EPS for the quarter, beating the Zacks’ consensus estimate of $0.34 by $0.02. The firm had revenue of $188 million for the quarter, compared to analysts’ expectations of $188.85 million. Phibro Animal Health Corp. had a net margin of 10.13% and a return on equity of 75.49%. The firm’s revenue was up .5% on a year-over-year basis. During the same period in the prior year, the company earned $0.44 EPS. On average, equities research analysts predict that Phibro Animal Health Corp. will post $1.42 earnings per share for the current year.

The business also recently disclosed a quarterly dividend, which will be paid on Wednesday, December 21st. Stockholders of record on Wednesday, November 30th will be issued a dividend of $0.10 per share. The ex-dividend date of this dividend is Monday, November 28th. This represents a $0.40 annualized dividend and a dividend yield of 1.39%. Phibro Animal Health Corp.’s payout ratio is currently 21.05%.

Hedge funds and other institutional investors have recently made changes to their positions in the company. Municipal Employees Retirement System of Michigan raised its position in shares of Phibro Animal Health Corp. by 1.7% in the third quarter. Municipal Employees Retirement System of Michigan now owns 4,110 shares of the company’s stock valued at $112,000 after buying an additional 70 shares during the last quarter. BNP Paribas Arbitrage SA raised its position in shares of Phibro Animal Health Corp. by 102.6% in the second quarter. BNP Paribas Arbitrage SA now owns 6,150 shares of the company’s stock valued at $115,000 after buying an additional 3,114 shares during the last quarter. Nuveen Fund Advisors LLC bought a new position in shares of Phibro Animal Health Corp. during the second quarter valued at $196,000. Advisors Preferred LLC bought a new position in shares of Phibro Animal Health Corp. during the third quarter valued at $213,000. Finally, Capstone Asset Management Co. bought a new position in shares of Phibro Animal Health Corp. during the third quarter valued at $214,000. Institutional investors and hedge funds own 47.62% of the company’s stock.

Phibro Animal Health Corp. Company Profile

Phibro Animal Health Corporation is an animal health and mineral nutrition company. The Company is engaged in developing, manufacturing and marketing products for a range of food animals, including poultry, swine, beef and dairy cattle, and aquaculture. The Company operates through three segments: Animal Health, Mineral Nutrition and Performance Products.

5 Day Chart for NASDAQ:PAHC

Receive News & Stock Ratings for Phibro Animal Health Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phibro Animal Health Corp. and related stocks with our FREE daily email newsletter.